ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2025 CME AANEM Program - Seek, Find, and Treat: Best Practices for Managing Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN)

By: PRLog
This CME Symposium takes place VIRTUALLY on Wednesday, October 29, 2025, from 11:30 AM - 12:30 PM PDT during the 2025 Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine.

HAZLET, N.J. - Oct. 7, 2025 - PRLog -- In this program, experts Drs. Morie Gertz, Michelle Mauermann, Sami Khella, and Ronald Witteles will describe best practices for the diagnosis, treatment, and monitoring of disease progression in these patients.

Click here for more information and registration

CHAIR

Morie Gertz, MD, MACP

Chair Emeritus, Department of Internal Medicine
Ronald Seidler Jr. Professor of Medicine
Mayo Distinguished Clinician
Mayo Clinic
Rochester, Minnesota

FACULTY

Sami Khella, MD

Professor of Neurology
University of Pennsylvania School of Medicine
Former Chief of Neurology
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania

Michelle Mauermann, MD
Professor of Medicine
Chair, Division of Neuromuscular Medicine
Mayo Clinic
Rochester, Minnesota

Ronald Witteles, MD
Professor of Medicine (Cardiovascular Medicine)
Co-Director, Stanford Amyloid Center
Stanford University School of Medicine
Stanford, California

Educational Objectives
- Recognize red flags for raising suspicion of ATTRv amyloidosis with polyneuropathy (PN)
- Describe key considerations and recommended assessments for diagnosis of ATTRv with polyneuropathy
- Explain clinical evidence for treatments of ATTRv with PN
- Discuss best practices for diagnosis and treatment of patients with mixed phenotype
- Identify assessments/tools for monitoring disease progression

Target Audience
This educational activity is intended for clinicians managing patients with ATTR-PN.

Educational Grant
Voxmedia gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals LP and Ionis Pharmaceuticals.

Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.0 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Contact
Voxmedia, LLC
***@voxmedia.us

Photos: (Click photo to enlarge)

Voxmedia Logo 2025 AANEM CME Program


Source: CMEPlanet

Read Full Story - 2025 CME AANEM Program - Seek, Find, and Treat: Best Practices for Managing Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN) | More news from this source

Press release distribution by PRLog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.